Publications by authors named "David Workman"

Claim this Profile
C
Correction to "Selecting Counterions to Improve Ionized Hydrophilic Drug Encapsulation in Polymeric Nanoparticles".
Savvas Dimiou, James McCabe, Rebecca Booth, Jonathan Booth, Kalyan Nidadavole, David Workman

Mol Pharm· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the physical-chemical properties of poly(lactic acid)-poly(ethylene glycol) polymeric nanoparticles on biodistribution.
Mark J Jackman, Weimin Li, Aaron Smith, David Workman, Kevin E Treacher

J Control Release· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quaternary Ammonium Palmitoyl Glycol Chitosan (GCPQ) Loaded with Platinum-Based Anticancer Agents-A Novel Polymer Formulation for Anticancer Therapy.
Yvonne Lerchbammer-Kreith, Michaela Hejl, Nadine S Sommerfeld, Xian Weng-Jiang, Uchechukwu Odunze, David G Workman

Pharmaceuticals (Basel)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selecting Counterions to Improve Ionized Hydrophilic Drug Encapsulation in Polymeric Nanoparticles.
Savvas Dimiou, James McCabe, Rebecca Booth, Jonathan Booth, Kalyan Nidadavole, David Workman

Mol Pharm· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain Gene Silencing with Cationic Amino-Capped Poly(ethylene glycol) Polyplexes.
Abdullah A Alamoudi, Paula A Méndez, David Workman, Andreas G Schätzlein, Ijeoma F Uchegbu

Biomedicines· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Special Forces Medical Sergeant/Special Operations Independent Duty Corpsman Candidates: Large Animal Module.
John Kenneth Yost, Jarred Yates, Brad Smith, David J Workman, Darrin Matlick

J Spec Oper Med· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of linkages between 1-hydroxy-2(1H)-pyridinone coordinating groups and a tris(2-aminoethyl)amine core in a novel series of synthetic hexadentate iron(III) chelators on antimicrobial activity.
David G Workman, Michael Hunter, Shuning Wang, Jérémy Brandel, Véronique Hubscher

Bioorg Chem· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Limiting the level of tertiary amines on polyamines leads to biocompatible nucleic acid vectors.
Margarida Isabel Simão Carlos, Kai Zheng, Natalie Garrett, Natrah Arifin, David G Workman

Int J Pharm· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of novel Iron(III) chelators based on triaza macrocycle backbone and 1-hydroxy-2(H)-pyridin-2-one coordinating groups and their evaluation as antimicrobial agents.
David G Workman, Michael Hunter, Lynn G Dover, David Tétard

J Inorg Biochem· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining the optimal formulation and schedule of a candidate toxoid vaccine against Clostridium difficile infection: A randomized Phase 2 clinical trial.
Guy de Bruyn, Jamshid Saleh, David Workman, Richard Pollak, Victor Elinoff

Vaccine· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protection from neurodegeneration in the 6-hydroxydopamine (6-OHDA) model of Parkinson's with novel 1-hydroxypyridin-2-one metal chelators.
David G Workman, Andrew Tsatsanis, Frank W Lewis, John P Boyle, Maryam Mousadoust

Metallomics· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis